MedPath

Which is the best ultra-rapid acting insulin to improve postprandial glycemic variability? Comparison of insulin glulisine vs. insulin lispro vs. insulin aspart using FreeStyle Libre Pro: randomised triple crossover study

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000027368
Lead Sponsor
General Inuyamachuo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with severe renal dysfunction (serum creatinine level more than 2.0 mg/dL) Patients who were aware that they were hypoglycemic and took glucose tablets Patients considered not suitable for participation due to medical reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath